First-Line Treatment for ADHD in Adult Women

Treatment Algorithm

The American College of Obstetrics and Gynecology recommends amphetamine-based stimulants as the first-line pharmacological treatment for adult women with moderate to severe ADHD, with effectiveness rates of 70-80%, and should be combined with cognitive behavioral therapy for optimal outcomes 1, 2
For moderate to severe ADHD, the American College of Obstetrics and Gynecology suggests initiating combination therapy with psychostimulants plus psychotherapy as the gold standard 1, 2
The American College of Obstetrics and Gynecology recommends beginning with psychoeducation, CBT, and mindfulness-based interventions for mild ADHD or patient preference for non-pharmacological approach 2, 3

The American College of Obstetrics and Gynecology specifically recommends amphetamine-based stimulants (amphetamine, dexamphetamine, lisdexamfetamine) for adults based on recent meta-analysis data 1, 4, 5
The American College of Obstetrics and Gynecology suggests that methylphenidate is recommended primarily for children and adolescents, though it remains effective in adults 6, 5
The American College of Obstetrics and Gynecology states that stimulants demonstrate superior efficacy compared to all non-stimulant options 2, 7

The American College of Obstetrics and Gynecology recommends that Cognitive Behavioral Therapy (CBT) should be initiated concurrently with medication, as it is the most extensively studied and effective psychotherapy for ADHD in adults 1, 2, 3
The American College of Obstetrics and Gynecology suggests that CBT targets executive functioning skills: time management, organization, planning, emotional self-regulation, stress management, and impulse control 2, 6
The American College of Obstetrics and Gynecology states that CBT effectiveness is significantly enhanced when combined with medication rather than used alone 1, 2

The American College of Obstetrics and Gynecology recommends that if pregnancy is being contemplated or confirmed, treatment decisions become more complex, and a risk-benefit analysis is imperative 1, 4, 5
The American College of Obstetrics and Gynecology states that amphetamines do not appear associated with major congenital malformations, though possible small increased risks for gastroschisis and preeclampsia have been reported 5
The American College of Obstetrics and Gynecology suggests that untreated ADHD in pregnancy is associated with increased risks for spontaneous abortion and preterm birth 5
The American College of Obstetrics and Gynecology recommends that discontinuing stimulants during pregnancy can lead to worse mental health outcomes and significant functional impairments 5

The American College of Obstetrics and Gynecology states that untreated or severe ADHD significantly impairs driving capability; stimulant treatment improves this 2, 6
The American College of Obstetrics and Gynecology suggests that bupropion may be preferred when stimulant misuse or diversion is a concern 8